Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.37 |
| ▸ | RELA | Q04206 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16441649 | 0.97 | ABCG2 (0.39) | TSHRADORA3ALOX15ADORA2AADORA2B | |
| SCHEMBL16441657 | 0.94 | MEN1 (0.38) | TSHRABCG2MEN1GAAKMT2A | |
| SCHEMBL21157076 | 0.93 | ABCG2 (0.37) | TSHRABCG2MEN1GAAKMT2A | |
| SCHEMBL14296098 | 0.92 | KDM4E (0.44) | TSHRADORA3ALOX15ADORA2AADORA2B | |
| SCHEMBL25749784 | 0.92 | MEN1 (0.46) | TSHRADORA2AADORA1MEN1GAA | |
| SCHEMBL21365828 | 0.91 | MEN1 (0.38) | TSHRMEN1KMT2AL3MBTL1KDM4E | |
| SCHEMBL21157911 | 0.91 | MEN1 (0.37) | TSHRABCG2MEN1GAAKMT2A | |
| SCHEMBL25749786 | 0.90 | MEN1 (0.42) | TSHRADORA2AADORA1MEN1GAA | |
| SCHEMBL18676965 | 0.89 | L3MBTL1 (0.46) | TSHRABCG2MEN1GAAKMT2A | |
| SCHEMBL17853074 | 0.88 | MEN1 (0.46) | ADORA2AADORA1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210004-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-06-29 | — | — | US | disclosed |
| US-20230210004-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-06-29 | — | — | US | disclosed |
| US-11588117-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2023-02-21 | — | — | US | disclosed |
| EP-3647393-A1 | MATERIALS FOR ELECTRONIC DEVICES | Merck Patent GmbH (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-20160181548-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2016-06-23 | — | — | US | disclosed |
| US-20160181548-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2016-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160181548-A1 | MATERIALS FOR ELECTRONIC DEVICES | EPHB3, EPHA3, EPHB4 | TSHR 4540/4885ADORA3 3074/4885ALOX15 2939/4885 |
| US-20230210004-A1 | MATERIALS FOR ELECTRONIC DEVICES | EPHB3, EPHA3, EPHB4 | TSHR 4540/4885ADORA3 3074/4885ALOX15 2939/4885 |
| US-11588117-B2 | Materials for electronic devices | EPHB3, EPHA3, EPHB4 | TSHR 4540/4885ADORA3 3074/4885ALOX15 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.